haya therapeutics
HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.
Total raised
€58M
€57,546,341
Funding rounds
2
Investors
12
distinct backers
Active since
2019-09
latest 2025-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood55
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 7y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-08 | Series A | €57M | +ND Capital,4see Ventures,Alexandria Venture Investments,Apollo Health Ventures,ATHOS CAPITAL,Bernina BioInvest+6 more | View deal → |
| 2019-10-01 | Other | €86k | — | View deal → |
Investors
12Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy